U.S. Communications Stock News

Beam Therapeutics (BEAM) shares are in focus after the company reported updated Phase 1/2 data for its AATD candidate BEAM-302, selected 60 mg as the preferred dose, and outlined plans for an accelerated approval path. See our latest analysis for Beam Therapeutics. Despite the BEAM-302 update, Beam Therapeutics’ shares have lost ground in the short term, with a 30 day share price return of 13.19% and a 90 day share price return of 14.89%. However, the 1 year total shareholder return remains...

How TAL Education Group stock has been performing recently TAL Education Group (NYSE:TAL) has seen mixed share performance recently, with a 0.9% gain over the past month, a similar rise over the past 3 months, and a negative 15.2% total return over the past year. Over longer horizons, the picture is very different. The 3 year total return is very large at around 7x, while the 5 year total return shows a 79.3% decline, underlining how timing has mattered for investors. Year to date, the stock...

Ecosuite announced that it has been selected by the District of Columbia Public Service Commission, alongside partner Ecogy Energy and with support from Exelon unit Pepco, for a 5‑year pilot to test how rooftop solar, battery storage and EV charging can be managed to improve local grid efficiency and reliability. This pilot puts Exelon, through Pepco, at the center of experimenting with customer‑sited energy resources that could influence how future distribution systems are planned and...

Wondering whether Prosperity Bancshares at around US$66 is offering good value today, or if the price already reflects its strengths? This article breaks down what the numbers are really saying about the stock. The share price is around US$66.41 after a recent 2.9% gain over the last 7 days, set against a 9.7% decline over 30 days and a 4.6% decline year to date and over 1 year, with a 3 year return of 18.6% and 5 year return of 2.8%. Recent coverage has focused on how Prosperity Bancshares...

Earlier this month, Anthropic announced that its Claude AI assistant can autonomously control computers, triggering concerns that value could shift from traditional application software toward the intelligence layer and put pressure on established providers like AppLovin in advertising technology. At the same time, AppLovin has been emphasizing the role of its first-party data and Axon 2.0 machine learning stack, highlighting how proprietary AI capabilities may influence its resilience as...

Upcoming Q1 earnings and shifting expectations Wells Fargo (WFC) heads into its Q1 2026 earnings report with analysts expecting profit of $1.56 per share, while at least one major brokerage has recently trimmed assumptions around net interest income and buybacks. See our latest analysis for Wells Fargo. At a share price of US$79.61, Wells Fargo has seen a 1-day share price return of 1.70% and 7-day share price return of 4.43%, although its 30-day and year to date share price returns are...

Alignment Healthcare CEO John E. Kao has arranged the indirect sale of 118,000 shares in NasdaqGS:ALHC under a preplanned trading program. The transaction is part of a trading plan that schedules sales in advance, rather than a one off discretionary move. Kao retains a substantial shareholding after the sale, keeping significant exposure to the company. For investors watching NasdaqGS:ALHC, this insider activity comes at a time when the stock trades at $17.42, with a 3 year return of 181.4%...

Stock performance snapshot Eli Lilly (LLY) has seen its share price retreat recently, with a 1 day return of 0.8%, a 1 week move of 2.9%, and a month performance of 10.5% in the red. Over the past 3 months, the stock is down 16.2%, with the year to date return at 16.4% lower. Even so, the 1 year total return sits at 6.7%, and the 3 year and 5 year total returns are very large multiples of the starting value. See our latest analysis for Eli Lilly. The recent 30 day share price return of 10.6%...

On March 18, 2026, Core Scientific, Inc. amended its delayed-draw bridge credit agreement, doubling total term loan commitments to US$1.00 billion and drawing the additional US$500.00 million to fund data center infrastructure, equipment, land, and energy procurement. This sizeable, fully drawn facility backed by Morgan Stanley and JPMorgan underscores lenders’ confidence in Core Scientific’s expansion plans and capital-intensive AI and high-performance computing ambitions. Next, we’ll...

If you are wondering whether Nelnet's current share price still offers value or if most of the opportunity is already priced in, this article will help you frame that question clearly. With the stock at US$129.60 and returns of 1.2% over 7 days, 0.5% year to date, and 16.9% over 1 year, recent performance provides a useful backdrop before looking at what the business might be worth. Recent news coverage about Nelnet has focused on its role as a diversified financial services company and how...

General Motors (NYSE:GM) has begun supervised public road testing of its next generation hands free, eyes off automated driving system on highways in California and Michigan. More than 200 GM vehicles are running the technology in live traffic as part of this test phase. GM plans a commercial rollout of the system on the 2028 Cadillac Escalade IQ, signaling its intent to bring higher automation levels to a flagship model. For investors, this move sits at the intersection of GM's core auto...

VinFast Auto (NasdaqGS:VFS) is back in focus after recent analyst meetings highlighted its emphasis on long-term expansion, ecosystem buildout around charging and ride-hailing, and the backdrop of strong reported electric vehicle delivery figures. See our latest analysis for VinFast Auto. The recent analyst meetings and strong delivery updates have come against a weaker trading backdrop, with a 90 day share price return of 14.37% decline and a 3 year total shareholder return of 70.81%...

Wondering whether Applied Optoelectronics at around US$113.90 is still offering value or has already priced in much of its story? This article walks through what the current valuation signals are really saying. The share price has recently been volatile, with returns of 31.9% over 7 days, 120.4% over 30 days, 187.6% year to date, 423.2% over 1 year and a very large gain over 3 years and 5 years based on the data provided. Recent coverage has focused on these sharp moves in the share price...

Stock performance snapshot and business profile Globus Medical (GMED) is on investors’ radar after a recent pullback, with the stock showing a 1-day return of a 1.10% decline and a past month return of a 4.79% decline. Over the past 3 months, Globus Medical has recorded a 2.47% decline, while the 1-year total return stands at 12.55%. Year to date, the stock is down 1.20%, giving investors mixed signals on short-term sentiment. The company has a market value of about US$11.80b and focuses on...

In recent weeks, Lakeland Financial Corporation director M. Scott Welch executed three open‑market purchases of LKFN common stock between February 27 and March 12, 2026, marking his first meaningful increase in beneficial ownership since March 2025. This cluster of insider buying stands out as a clear signal that a key board member is willing to commit additional personal capital amid sector uncertainty. We’ll examine how this recent insider buying flurry by Director M. Scott Welch shapes...

If you are wondering whether Ocugen's current share price still makes sense after a strong run, the key question is how that price lines up with the underlying value of the business. Ocugen shares, which last closed at US$1.92, have had a mixed but attention grabbing run, with a 21.6% decline over the last 7 days, a 20.0% gain over 30 days, 39.1% year to date, 168.6% over 1 year and 131.3% over 3 years, set against a 71.6% loss over 5 years. Recent news coverage has focused on Ocugen's...

Earlier in 2026, Uniti’s Kinetic business unit was named CNET’s Best Rural Fiber Internet Provider for the second consecutive year, as it pursues a multi‑year fiber build aimed at reaching about 2.3 million homes by the end of 2026 and roughly 3.5 million homes by 2029. This recognition highlights Kinetic’s role in extending multi‑gigabit connectivity to rural and suburban communities, underlining Uniti’s focus on digital equity and infrastructure-led growth. We’ll now examine how Kinetic’s...

Index inclusion puts Natural Resource Partners (NRP) on more investors' radar Natural Resource Partners (NRP) was recently added to the S&P/TSX Global Mining Index, an event that can increase its visibility as index tracking funds and institutional investors review their allocations. See our latest analysis for Natural Resource Partners. That index inclusion comes after a period of strong momentum, with a 90 day share price return of 21.30% and a 1 year total shareholder return of 22.54%,...

Bunge Global (BG) has drawn fresh attention after recent share price moves, with the stock up about 1.8% over the past month and roughly 40% over the past 3 months. See our latest analysis for Bunge Global. The recent 90 day share price return of 39.9% and 1 year total shareholder return of 74.2% suggest momentum has been strong, even if the latest 7 day share price move has paused that trend. If this kind of move has you thinking about what else might be setting up for strong performance, it...

Bitmine Immersion Technologies (BMNR) has drawn fresh attention after recent trading left the stock with mixed returns. The shares fell 10.5% over the past week, while posting a gain over the past month. See our latest analysis for Bitmine Immersion Technologies. At a latest share price of $20.80, Bitmine Immersion Technologies has seen weak short term momentum, with a 1 day share price return of 2.21% decline and a 90 day share price return of 29.13% decline. This contrasts with a 1 year...

If you are wondering whether Nutanix at around US$39.31 is a bargain, expensive, or somewhere in between, the starting point is to look closely at what the current price actually reflects. The stock has seen a 5.7% decline over the last 7 days and is down 22.3% year to date, yet it still shows a 58.4% return over 3 years and 52.0% over 5 years. This combination can leave the current valuation looking unclear. Recent news coverage has focused on Nutanix as a key name in software and cloud...

Cipher Digital recently executed its third data center campus lease, a 15-year agreement with an investment-grade hyperscale tenant to develop and deliver a new high-performance computing facility at one of its existing sites. At the same time, the company secured an undrawn US$200.00 million revolving credit facility with an additional US$50.00 million accordion, strengthening liquidity and underpinning its shift toward high-performance computing infrastructure alongside bitcoin...

Investors may be wondering whether Madrigal Pharmaceuticals, at around US$445 a share, still offers value or if most of the opportunity has already been priced in. The stock has recent returns of 0.4% over 7 days, 2.3% over 30 days, a 25.1% decline year to date, and a 29.6% return over 1 year. This mixed performance can leave investors unsure how to read the risk and reward trade off. These moves sit against a backdrop where Madrigal Pharmaceuticals continues to attract attention in the...

If you are wondering whether Revolution Medicines at around US$95.52 is still offering value after a strong run, the key question is how its current price stacks up against a range of valuation checks. The stock has seen a 3.6% decline over the past 7 days and a 6.2% decline over the past 30 days, yet it shows returns of 20.9% year to date and 148.4% over the last year, with a very large 3 year return and a 117.4% return over 5 years. Recent news has focused on Revolution Medicines as a high...